2004 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2004: 33 approvals, 0 patent expiries, 0 Phase 3 milestones.

FDA / EMA / MHRA approvals (33)

• 2004-08-03 — Cymbalta · Eli Lilly and Company · United States · Metabolic
• 2005 — Aryplase · BioMarin · Metabolic
• 2005 — Mycamine · Teva Pharms Usa Inc · Infectious Disease
• 2005 — Increlex · Ipsen Inc · Metabolic
• 2005 — DIPHENHYDRAMINE CITRATE
• 2005 — LENALIDOMIDE
• 2005 — Joicela · Novartis Pharmaceuticals UK Limited · Immunology
• 2005 — TIPRANAVIR
• 2005 — TAMIBAROTENE
• 2005 — Arranon · Novartis · Oncology
• 2005 — Tygacil · Pfizer · Metabolic
• 2005 — Revlimid · Bristol-Myers Squibb · Oncology
• 2005 — Xibrom · Bausch Health · Ophthalmology
• 2005 — POSACONAZOLE
• 2005 — Nexavar · Bayer · Oncology
• 2005 — TOCILIZUMAB
• 2005 — IVABRADINE HYDROCHLORIDE
• 2005 — SORAFENIB TOSYLATE
• 2005 — Tetracaine Hydrochloride · Alcon Labs · Neuroscience
• 2005 — Byetta · AstraZeneca · Metabolic
• 2005 — Symlin · Astrazeneca Ab · Metabolic
• 2005 — MECASERMIN RINFABATE · Insmed · Other
• 2005 — Vaprisol In 5% Dextrose In Plastic Container · Cumberland · Cardiovascular
• 2005 — Orencia · Bristol-Myers Squibb · Immunology
• 2005 — Byetta · AstraZeneca · Metabolic
• 2005 — GADOFOSVESET TRISODIUM
• 2005 — Baraclude · Bristol-Myers Squibb · Infectious Disease
• 2005 — Exjade · Novartis · Other
• 2005 — Qualaquin · Sun Pharm Industries · Rare Disease
• 2005 — Levemir · Novo Nordisk · Metabolic
• 2005 — Nevanac · Harrow Health · Metabolic
• 2005 — Tygacil · Fresenius Kabi · Infectious Disease
• 2005 — Rozerem · Takeda · Metabolic

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.